DALLAS--(BUSINESS WIRE)--CCS — leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions — today announced PropheSee ™ a new, AI-powered ...
MASLD is prevalent in T2DM patients, with a 65% occurrence rate, and poses a higher risk for severe liver diseases. The study analyzed 3,836 T2DM patients, identifying key predictors like BMI, ...
Study of Over Three Million Patients for Risk of Type 2 Diabetes Demonstrates Potential for More Advanced Approach to Early Identification NEW ORLEANS, June 5, 2026 /PRNewswire/ -- A novel electronic ...
Medicine is rapidly evolving from statistical, evidence-based approaches to predictive, genotype-directed care, driven by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results